Clinical Trials in Gatineau, Canada
Locations / Gatineau, Canada
Delta Trials lists 273 clinical trials conducted in Gatineau, Canada, making it a notable site of clinical research activity. These trials addressing 157 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 48 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Gatineau research landscape.
273
Total Trials
157
Conditions
48
Terminated since 2020
Browse by condition (157 total)
- Alzheimer's disease 28 trialsAll Alzheimer's disease trials
- Multiple sclerosis 28 trialsAll Multiple sclerosis trials
- Diabetes mellitus, type 2 16 trialsAll Diabetes mellitus, type 2 trials
- Pulmonary disease, chronic obstructive 12 trialsAll Pulmonary disease, chronic obstructive trials
- Major depressive disorder 10 trialsAll Major depressive disorder trials
- Relapsing remitting multiple sclerosis 10 trialsAll Relapsing remitting multiple sclerosis trials
- All Multiple sclerosis, relapsing-remitting trials
- Alzheimer's disease 8 trialsAll Alzheimer's disease trials
- Relapsing multiple sclerosis 7 trialsAll Relapsing multiple sclerosis trials
- Cardiovascular disease 6 trialsAll Cardiovascular disease trials
- Type 2 diabetes 6 trialsAll Type 2 diabetes trials
- Herpes zoster 5 trialsAll Herpes zoster trials
- Prostate cancer 5 trialsAll Prostate cancer trials
- Hypercholesterolemia 5 trialsAll Hypercholesterolemia trials
- All Chronic obstructive pulmonary disease (COPD) trials
- Generalized anxiety disorder 4 trialsAll Generalized anxiety disorder trials
- Hypertension 4 trialsAll Hypertension trials
- Atherosclerosis 4 trialsAll Atherosclerosis trials
- Diabetes 4 trialsAll Diabetes trials
- Obesity 4 trialsAll Obesity trials